Trial Profile
Antihypertensive effect of combination therapy of telmisartan and low dose hydrochlorothiazide in hypertensive patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Hydrochlorothiazide (Primary) ; Telmisartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms FUJIYAMA Study 2
- 31 May 2016 New trial record